Previous Article | Next Article 
Journal of Virology, July 2005, p. 8614-8619, Vol. 79, No. 13
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.13.8614-8619.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Actin Is a Component of the Compensation Mechanism in Pseudorabies Virus Virions Lacking the Major Tegument Protein VP22
T. del Rio,
C. J. DeCoste, and
L.W. Enquist*
Department of Molecular Biology, Princeton University, Princeton, New Jersey 08540
Received 19 January 2005/
Accepted 24 March 2005

ABSTRACT
Despite being a major component of the pseudorabies virus tegument,
VP22 is not required for PRV replication, virulence, or neuroinvasion
(T. del Rio, H. C. Werner, and L. W. Enquist, J. Virol.
76:774-782,
2002). In the absence of VP22, tegument assembly compensates
in a limited fashion with increased incorporation of cellular
actin. Infection of epithelial cell lines expressing fluorescent
actin fusion proteins resulted in the incorporation of filamentous
and nonfilamentous actin into individual virions that were predominately
light, noninfectious particles. We conclude that cellular actin
is incorporated in the tegument of wild-type virions and is
part of a compensation mechanism for VP22-null virions.

TEXT
The herpes simplex virus type 1 and bovine herpesvirus homologues
of VP22, encoded by the UL49 gene, are major constituents of
the tegument layer (
13,
27,
31). However, deletion of UL49 from
pseudorabies virus (PRV) exhibited no phenotype in numerous
in vivo or in vitro assays. For example, the 50% lethal dose
and spread were indistinguishable from the parental virus following
infection of mouse flank, rat eye, and chicken allantoic membrane
(
2,
6,
9; unpublished results). Additionally, surface presentation
of major histocompatibility complex class I antigen was not
affected by loss of VP22 (reference
30 and unpublished results).
Virions lacking VP22 are able to infect cells and animals as
efficiently as wild-type virus, which suggests that VP22 has
no defined or fixed structural interactions during tegument
assembly. Consistent with this idea, incorporation of a green
fluorescent protein (GFP)-VP22 fusion protein in individual
heavy or light particles was heterogeneous, ranging from undetectable
to substantial (
10). We therefore determined whether PRV VP22
is a major component of a population of virions and whether
any proteins may compensate for its loss.
Evidence for tegument compensation in VP22-null virions.
For comparison of virion protein profiles, extracellular virions were purified by centrifugation on a linear tartrate gradient (5 to 20%) (10), separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE; 12.5%), and stained with Sypro Ruby Red (Molecular Probes). Sypro stain is fluorescent and reacts with primary amines at an acidic pH similar to a Coomassie blue binding action (3). Proteins were detected using UV illumination, and VP22 appeared as a single 34-kDa band in wild-type PRV Becker (Be) virions but not in VP22-null virions (PRV 175) (Fig. 1, left) (9). Clearly, VP22 is a major component of wild-type virions (Fig. 1, arrowhead in left lane [10 µg Be]) and a significant portion of the tegument mass (Fig. 2). We therefore investigated the protein profile of VP22-null (PRV 175) virions for differences relative to wild-type virions that may compensate for the loss of VP22. In VP22-null virions, three proteins of apparent molecular masses of 28, 46, and 53 kDa increased relative to other virion proteins (Fig. 1, right arrowheads). The 28-kDa and 46-kDa compensating proteins were sequenced by tandem mass spectrometry at the Harvard Microchemistry Facility and identified as PRV Us2 (a protein with a molecular weight of 28,000 [28K] from suid herpesvirus 1) and cellular actin (actin gamma; cytoskeletal type 5 from African clawed frog), respectively. The cellular actin found in lysates of PK15 cells migrated identically to actin identified in purified virions (Fig. 1). PRV Us2 protein is prenylated in infected cells, but the nonprenylated form is packaged in the tegument of virions (8). The 53-kDa protein was identified as PRV tegument protein VP16 (14) and reacts with a chicken polyclonal antibody against His-tagged PRV VP16 (PAS1200; Pro Science, Inc.) (data not shown). While virion incorporation of the 53-kDa form of VP16 increased following the loss of VP22, the 55-kDa form of VP16 was unchanged (Fig. 1). Western blot analysis confirmed the identity and relative increase of actin and Us2 in VP22-null virions, as well as the decrease of Us3 protein (data not shown).
Actin fractionates with components of the tegument layer in a virion sedimentation assay.
Cellular actin has been previously shown to be a major tegument
protein of Epstein-Barr virus (
18). To verify the tegument location
of actin in PRV, we sedimented 10 µg of purified Becker
virions (100-µl volume; 100,000
x g for 30 min at 4°C)
(Beckman TLA-100 rotor) de-enveloped with 1% NP-40 detergent
and analyzed the protein distribution between supernatant and
pellet fractions by SDS-PAGE and Sypro Ruby Red staining. VP22
was not detected in the detergent-solubilized fraction but was
abundantly released by treatment with detergent plus 1 M NaCl
(
9). Unlike VP22, the tegument proteins VP16 and Us2, as well
as cellular actin, were partially solubilized by 1% NP-40 treatment
(Fig.
2, filled arrowheads). The major capsid protein (MCP),
identified by Western blot analysis (data not shown), associated
with the pellet in the presence or absence of 1 M NaCl (Fig.
2). At least six other proteins behaved similarly to MCP, suggesting
that the intact capsid was pelleted (Fig.
2, open arrowheads).
The largest protein is likely to be the VP1/2 tegument protein
homologue (>300 kDa [
21]), which remains tightly associated
with the capsid (Fig.
2). Despite treatment with 1 M NaCl, a
fraction of the tegument proteins VP16, Us2, and actin remains
associated with the capsid pellet. It is notable that the fractionation
properties of virion-associated actin in this assay are similar
to those of Us2 and VP16, the other tegument proteins whose
incorporation is also detectably elevated in VP22-null virions.
One idea is that actin, Us2, and VP16 may form patches or domains
of tegument beneath the viral envelope. Another virion component
of approximately 105 kDa was significantly solubilized by 1%
NP-40 treatment (Fig.
2) and may also be a component of the
same outer domain of the tegument layer. We predicted that VP22
would be a component of these patches, but the sedimentation
assay was not consistent with this prediction. One explanation
for this discrepancy is that the sedimentation properties of
VP22 extracted from virions do not reflect these proposed outer
tegument patches but, rather, other properties of the protein.
For example, VP22 has been reported to interact with microtubules,
cell membranes, nonmuscle myosin IIA, and not only DNA but also
condensed chromosomes and the cellular DNA chaperone TAF-1 (
5,
11,
12,
34,
35), and these varied interaction properties may
affect the outcome of the biochemical assay presented here.
We conclude that cellular actin in virions fractionates with
the tegument proteins Us2 and VP16. Collectively, these proteins
may comprise a distinctive outer tegument shell solubilized
by detergent.
Direct visualization of GFP-actin in individual wild-type virions.
We investigated whether ectopically expressed GFP-actin could be incorporated into wild-type virions and whether there is a preference to incorporate actin monomers or filaments. A commercially available pEGFP-actin (with enhanced GFP; BD-Clontech) construct was used to produce PK15 cell lines directing incorporation of GFP fused to human ß-actin into microfilaments. We also introduced a Gly13Arg (G13R) point mutation previously shown to prevent incorporation into filaments (26). During site-directed mutagenesis (Transformer Site-Directed Mutagenesis Kit; BD-Clontech), a second site mutation, Asp11Glu (D11E), which does not affect actin incorporation into filaments or interaction with myosin-S1 (29), arose spontaneously.
PK15 cells stably expressing the fusion proteins GFP-F-actin (GFP-filamentous-actin from pEGFP-actin) or GFP-G-actin (GFP-globular-actin from pTD58) were made by the calcium phosphate transfection method (15) and subsequent expansion under G418 selection (800 µg/ml) (geneticin; Gibco-BRL). Two homogenous cell lines expressing comparable levels of fusion proteins, GFP-F-actin line 74 and GFP-G-actin line 52, were selected by several rounds of fluorescence-activated cell sorting and expansion (Fig. 3A). Despite easy visualization by fluorescence microscopy, ectopic GFP-actin was not readily detected by Western blotting using the actin AC15 antibody (Sigma) (data not shown). However, the fusion proteins were detected using a GFP monoclonal antibody (Chemicon) (Fig. 3B). Phalloidin-rhodamine staining (Molecular Probes) detected filamentous actin and revealed the incorporation of GFP-F-actin into microfilaments (Fig. 3C, frames a and b). In contrast, GFP-G-actin is not incorporated into filamentous actin (Fig. 3C, frame c), is largely nonnuclear, and likely remains associated with the cytoplasmic pool of monomeric or globular actin. GFP-F-actin must also still exist in the globular state, but as evident by the localization of GFP-F-actin in PK15 cells (Fig. 3C), the steady-state concentration of the globular form is reduced.
To determine virion incorporation and detection levels, the
nonsorted cell line GFP-F-actin 2, which was available before
the sorted lines but exhibited heterogeneous amounts of fluorescence
(data not shown), was first infected with PRV Becker. Extracellular
virions produced from GFP-actin-expressing cells were purified
as above and diluted with an equal volume of glycerol. The punctate
GFP autofluorescence of single virions was revealed by confocal
microscopy and was brighter in particles isolated from the light
band relative to those from the heavy band (Fig.
4A). Since
light particles contain more tegument mass than heavy particles
and incorporate an increased amount of the GFP-VP22 tegument
fusion (
10), it is likely that light particles contain more
actin and incorporate more GFP-actin. We tested this using a
recombinant PRV expressing a fluorescent red capsid (PRV 180),
which enables the direct identification of individual heavy
and light particles (
10). When isolated from infected PK15 cells,
red capsid virions exhibit no green fluorescence (Fig.
4B).
Occasionally, GFP-F-actin colocalized with red capsid puncta
(Fig.
4C, filled arrowheads), but the majority of the green
signal localized to light particles. Similar to our previous
observations for GFP-VP22, we also occasionally observed GFP-F-actin
puncta juxtaposed to red capsid puncta (Fig.
4C, open arrowheads),
reminiscent of the asymmetrical tegument cap described by Grunewald
et al. (
17). Incorporated GFP-G-actin was more difficult to
detect and, in this assay, was only observed in light particles
(Fig.
4D). We have not established the lower limits of detection
of GFP-actin; therefore, negative results must be interpreted
accordingly. However, similar to results for GFP-VP22, an increased
amount of GFP-actin is detected in light particles relative
to heavy particles.
We demonstrate that actin incorporation increases in the absence
of the major tegument protein VP22 and fractionates with other
tegument proteins. In addition, GFP-actin is more readily detectable
in light particles, which contain an increased tegument mass
relative to infectious heavy particles. At present, given the
current technology and lack of understanding of light-particle
formation, we cannot easily quantitate and compare differences
in single components of the tegument mass of light and heavy
particles. The fact that we were able to detect GFP-actin in
light particles and only occasionally in heavy particles is
consistent with the idea that light particles contain more tegument
mass and, in addition, that we are at or near the detection
limit of GFP-actin in the tegument. Taken together, the data
demonstrate that the majority of actin in PRV virions resides
within the tegument layer. These data confirm and extend previous
results suggesting that actin is internally localized in the
pseudorabies virion (
32). Virion-associated actin has been reported
in other herpesviruses (
1,
17,
19,
32,
36,
38) and other enveloped
viruses including paramyxovirus, retrovirus, and rhabdovirus
(
4,
23,
24,
25,
28,
33). One hypothesis to explain this general
finding is that actin plays an active role in virus budding.
For example, it has been proposed that filamentous actin depolymerization
occurs coincident with human immunodeficiency virus virion budding
(
7). Similarly, microfilaments of a size consistent with polymerized
actin have been visualized within the reticular structure of
the herpes simplex virion tegument (
17). It may be that actin
microfilament depolymerization occurs only at the forming herpesvirus
envelope-tegument interface, while polymerized actin remains
embedded in the outer tegument layer following budding. However,
this model does not provide a rationale for the incorporation
of globular actin. Therefore, we cannot rule out the possibility
that some tegument-associated actin is acquired passively during
secondary envelopment.
Actin is a dynamic component of pseudorabies virus assembly whose levels of incorporation can be altered by the deletion of a major tegument protein (Fig. 1). One key question concerns the mechanism that can provide such flexibility in outer tegument formation. While little is understood about tegument assembly and incorporation in light particles, it is likely that the innermost tegument layer consisting in part of UL36 and UL37 proteins interacts with the capsid in heavy particles (20, 37). This conclusion is supported by entry assays demonstrating that UL36 (VP1/2), UL37, and Us3 remain associated with cytoplasmic capsids following entry and penetration (16, 22). In addition, these same studies found that UL11, UL47 (VP13/14), UL48 (VP16), and UL49 (VP22) tegument proteins are lost following virion entry and uncoating. These proteins are likely to be components of the outer tegument layer. One interpretation of these data and our findings is that cellular actin, Us2, and the 53-kDa form of VP16 are components of the outer tegument layer that contains VP22. We have reported that the incorporation of a GFP-VP22 fusion protein in single virions ranged from undetectable to highly abundant (10). Therefore, the composition of the outer tegument shell, which may be equivalent to the tegument cap (17), appears to be flexible and heterogeneous. We postulate that the 55-kDa form of VP16, whose incorporation does not increase in VP22-null virions, is not a component of the flexible network of protein interactions in this outer tegument layer. At present, it is unclear whether the 55-kDa form of VP16 is associated with the inner tegument layer as predicted by this model of tegument assembly. It is also unknown whether the flexible outer tegument network is present only at the tegument-envelope interface or at other sites within the tegument. It is possible that actin-binding sites in the outer tegument layer increase in the absence of VP22, but we have been unable to localize or resolve such putative binding sites. Viral proteins involved in the assembly process may interact with actin and lead to specific incorporation of a fraction of the abundant cellular protein in the tegument. Nevertheless, our data are consistent with the formation of a dynamic, flexible outer tegument shell in herpesvirus particles. One prediction, therefore, is that PRV virions lacking other specific tegument components may contain variable amounts of actin. Further study of the origin and function of actin in PRV virions is likely to provide insight into herpes virion assembly and envelopment.

ACKNOWLEDGMENTS
We acknowledge Joe Goodhouse for expert help with confocal microscopy.
We thank Alex Flood for purification of the His-tagged VP16
used for antibody production and for the gift of a monoclonal
antibody specific for PRV major capsid protein.
This work was supported by National Institutes of Health (NIH) grant 2ROI-NS33506 to L.W. Enquist and an NIH Research Supplement for Underrepresented Minority to T. del Rio.

FOOTNOTES
* Corresponding author. Mailing address: Schultz Laboratory, Department of Molecular Biology, Princeton University, Princeton, NJ 08544-1014. Phone: (609) 258-2664. Fax: (609) 258-1035. E-mail:
lenquist{at}princeton.edu.

Present address: Neurobiology Section, Division of Biological Sciences, UCSD, 9500 Gilman Drive, La Jolla, CA 92093-0357. 

REFERENCES
1 - Baldick, C. J., Jr., and T. Shenk. 1996. Proteins associated with purified human cytomegalovirus particles. J. Virol. 70:6097-6105.[Abstract]
2 - Banfield, B. W., G. S. Yap, A. C. Knapp, and L. W. Enquist. 1998. A chicken embryo eye model for the analysis of alphaherpesvirus neuronal spread and virulence. J. Virol. 72:4580-4588.[Abstract/Free Full Text]
3 - Berggren, K., E Chernokalskaya, T. H. Steinberg, C. Kemper, M. F. Lopez, Z. Diwu, R. P. Haugland, and W. F. Patton. 2000. Background-free, high sensitivity staining of proteins in one- and two-dimensional sodium dodecyl sulfate-polyacrylamide gels using a luminescent ruthenium complex. Electrophoresis 21:2509-2521.[CrossRef][Medline]
4 - Bohn, W., K. Mannweiler, H. Hohenberg, and G. Rutter. 1987. Replica-immunogold technique applied to studies on measles virus morphogenesis. Scanning Microsc. 1:319-330.[Medline]
5 - Brignati, M. J., J. S. Loomis, J. W. Wills, J., and R. J. Courtney. 2003. Membrane association of VP22, a herpes simplex virus type 1 tegument protein. J. Virol. 77:4888-4898.[Abstract/Free Full Text]
6 - Brittle, E. E., A. E. Reynolds, and L. W. Enquist. 2004. Two modes of pseudorabies virus neuroinvasion and lethality in mice. J. Virol. 78:12951-12963.[Abstract/Free Full Text]
7 - Chen, C., O. A. Weisz, D. B. Stolz, S. C. Watkins, and R. C. Montelaro. 2004. Differential effects of actin cytoskeleton dynamics on equine infectious anemia virus particle production. J. Virol. 78:882-891.[Abstract/Free Full Text]
8 - Clase, A. C., M. G. Lyman, T. del Rio, J. A. Randall, C. M. Calton, L. W. Enquist, and B. W. Banfield. 2003. The pseudorabies virus Us2 protein, a virion tegument component, is prenylated in infected cells. J. Virol. 77:12285-12298.[Abstract/Free Full Text]
9 - del Rio, T., H. C. Werner, and L. W. Enquist. 2002. The pseudorabies virus VP22 homologue (UL49) is dispensable for virus growth in vitro and has no effect on virulence and neuronal spread in rodents. J. Virol. 76:774-782.[Abstract/Free Full Text]
10 - del Rio, T., T. H. Ch'ng, A. E. Flood, S. P. Gross, and L. W. Enquist. 2005. Heterogeneity of a fluorescent tegument component in single pseudorabies virions and enveloped axonal assemblies. J. Virol. 79:3903-3919.[Abstract/Free Full Text]
11 - Elliott, G., and P. O'Hare. 1998. Herpes simplex virus type 1 tegument protein VP22 induces the stabilization and hyperacetylation of microtubules. J. Virol. 72:6448-6455.[Abstract/Free Full Text]
12 - Elliott, G., and P. O'Hare. 1999. Live-cell analysis of a green fluorescent protein-tagged herpes simplex virus infection. J. Virol. 73:4110-4119.[Abstract/Free Full Text]
13 - Elliott, G. D., and D. M. Meredith. 1992. The herpes simplex virus type 1 tegument protein VP22 is encoded by gene UL49. J. Gen. Virol. 73:723-726.[Abstract/Free Full Text]
14 - Fuchs, W., H. Granzow, B. G. Klupp, M. Kopp, and T. C. Mettenleiter. 2002. The UL48 tegument protein of pseudorabies virus is critical for intracytoplasmic assembly of infectious virions. J. Virol. 76:6729-6742.[Abstract/Free Full Text]
15 - Graham, R. L., and A. S. Van der Eb. 1973. A new technique for the assay of infection of human adenovirus 5 DNA. Virology 52:456-467.[CrossRef][Medline]
16 - Granzow, H., B. G. Klupp, and T. C. Mettenleiter. 2005. Entry of pseudorabies virus: an immunogold-labeling study. J. Virol. 79:3200-3205.[Abstract/Free Full Text]
17 - Grunewald, K., P. Desai, D. C. Winkler, J. B. Heymann, D. M. Belnap, W. Baumeister, and A. C. Steven. 2003. Three-dimensional structure of herpes simplex virus from cryo-electron tomography. Science 302:1396-1398.[Abstract/Free Full Text]
18 - Johannsen, E., M. Luftig, M. R. Chase, S. Weicksel, E. Cahir-McFarland, D. Illanes, D. Sarracino, and E. Kieff. 2004. Proteins of purified Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 101:16286-16291.[Abstract/Free Full Text]
19 - Kattenhorn, L. M., R. Mills, M. Wagner, A. Lomsadze, V. Makeev, M. Borodovsky, H. L. Ploegh, and B. M. Kessler. 2004. Identification of proteins associated with murine cytomegalovirus virions. J. Virol. 78:11187-11197.[Abstract/Free Full Text]
20 - Klupp, B. G., W. Fuchs, H. Granzow, R. Nixdorf, and T. C. Mettenleiter. 2002. Pseudorabies virus UL36 tegument protein physically interacts with the UL37 protein. J. Virol. 76:3065-3071.[Abstract/Free Full Text]
21 - Klupp, B. G., C. J. Hengartner, T. C. Mettenleiter, and L. W. Enquist. 2004. Complete, annotated sequence of the pseudorabies virus genome. J. Virol. 78:424-440.[Abstract/Free Full Text]
22 - Luxton, G. W. G., S. Haverlock, K. E. Coller, S. E. Antinone, A. Pincetic, and G. A. Smith. Targeting of herpesvirus capsid transport in axons is coupled to association with specific sets of tegument proteins. Proc. Natl. Acad. Sci. USA 102:5832-5837.
23 - Naito, S., and S. Matsumoto. 1978. Identification of cellular actin within the rabies virus. Virology 91:151-163.[CrossRef][Medline]
24 - Orvell, C. 1980. Structural polypeptides of canine distemper virus. Arch. Virol. 66:193-206.[CrossRef][Medline]
25 - Ott, D. E., L. W. Coren, B. P. Kane, L. K. Busch, D. G. Johnson, R. C. Sowder II, E. N. Chertova, L. O. Arthur, and L. E. Henderson. 1996. Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. J. Virol. 70:7734-7743.[Abstract]
26 - Posern, G., A. Sotiropoulos, and R. Treisman. 2002. Mutant actins demonstrate a role for unpolymerized actin in control of transcription by serum response factor. Mol. Biol. Cell 13:4167-4178.[Abstract/Free Full Text]
27 - Ren, X., J. S. Harms, and G. A. Splitter. 2001. Tyrosine phosphorylation of bovine herpesvirus 1 tegument protein VP22 correlates with the incorporation of VP22 into virions. J. Virol. 75:9010-9017.[Abstract/Free Full Text]
28 - Sagara, J., S. Tsukita, S. Yonemura, and A. Kawai. 1995. Cellular actin-binding ezrin-radixin-moesin (ERM) family proteins are incorporated into the rabies virion and closely associated with viral envelope proteins in the cell. Virology 206:485-494.[CrossRef][Medline]
29 - Solomon, T. L., L. R. Solomon, L. S. Gay, and P. A. Rubenstein. 1988. Studies on the role of actin's aspartic acid 3 and aspartic acid 11 using oligodeoxynucleotide-directed site-specific mutagenesis. J. Biol. Chem. 263:19662-19669.[Abstract/Free Full Text]
30 - Sparks-Thissen, R. L., and L. W. Enquist. 1999. Differential regulation of Dk and Kk major histocompatibility complex class I proteins on the cell surface after infection of murine cells by pseudorabies virus. J. Virol. 73:5748-5756.[Abstract/Free Full Text]
31 - Spear, P. G., and B. Roizman. 1972. Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpes virion. J. Virol. 9:143-159.[Abstract/Free Full Text]
32 - Wong, M. L., and C. H. Chen. 1998. Evidence for the internal location of actin in the pseudorabies virion. Virus Res. 56:191-197.[CrossRef][Medline]
33 - Vainiopaa, R., B. Ziola, and A. Salmi. 1978. Measles virus polypeptides in purified virions and in infected cells. Acta Pathol. Microbiol. Scand. Sect. B 86B:379-385.[Medline]
34 - van Leeuwen, H., G. Elliott, and P. O'Hare. 2002. Evidence of a role for nonmuscle myosin II in herpes simplex virus type 1 egress. J. Virol. 76:3471-3481.[Abstract/Free Full Text]
35 - van Leeuwen, H., M. Okuwaki, R. Hong, D. Chakravarti, K. Nagata, and P. O'Hare. 2003. Herpes simplex virus type 1 tegument protein VP22 interacts with TAF-I proteins and inhibits nucleosome assembly but not regulation of histone acetylation by INHAT. J. Gen. Virol. 84:2501-2510.[Abstract/Free Full Text]
36 - Varnum, S. M., D. N. Streblow, M. E. Monroe, P. Smith, K. J. Auberry, L. Pasa-Tolic, D. Wang, D. G. Camp II, K. Rodland, S. Wiley, W. Britt, T. Shenk, R. D. Smith, and J. A. Nelson. 2004. Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J. Virol. 78:10960-10966.[Abstract/Free Full Text]
37 - Zhou, Z. H., D. H. Chen, J. Jakana, F. J. Rixon, and W. Chiu. 1999. Visualization of tegument-capsid interactions and DNA in intact herpes simplex virus type 1 virions. J. Virol. 73:3210-3218.[Abstract/Free Full Text]
38 - Zhu, F. X., J. M. Chong, L. Wu, and Y. Yuan. 2005. Virion proteins of Kaposi's sarcoma-associated herpesvirus. J. Virol. 79:800-811.[Abstract/Free Full Text]
Journal of Virology, July 2005, p. 8614-8619, Vol. 79, No. 13
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.13.8614-8619.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Lyman, M. G., Enquist, L. W.
(2009). Herpesvirus Interactions with the Host Cytoskeleton. J. Virol.
83: 2058-2066
[Full Text]
-
Coller, K. E., Lee, J. I-H., Ueda, A., Smith, G. A.
(2007). The Capsid and Tegument of the Alphaherpesviruses Are Linked by an Interaction between the UL25 and VP1/2 Proteins. J. Virol.
81: 11790-11797
[Abstract]
[Full Text]
-
Baines, J. D., Hsieh, C.-E., Wills, E., Mannella, C., Marko, M.
(2007). Electron Tomography of Nascent Herpes Simplex Virus Virions. J. Virol.
81: 2726-2735
[Abstract]
[Full Text]
-
Lee, J. I-H., Luxton, G. W. G., Smith, G. A.
(2006). Identification of an Essential Domain in the Herpesvirus VP1/2 Tegument Protein: the Carboxy Terminus Directs Incorporation into Capsid Assemblons. J. Virol.
80: 12086-12094
[Abstract]
[Full Text]
-
Duffy, C., LaVail, J. H., Tauscher, A. N., Wills, E. G., Blaho, J. A., Baines, J. D.
(2006). Characterization of a UL49-Null Mutant: VP22 of Herpes Simplex Virus Type 1 Facilitates Viral Spread in Cultured Cells and the Mouse Cornea.. J. Virol.
80: 8664-8675
[Abstract]
[Full Text]
-
Michael, K., Klupp, B. G., Mettenleiter, T. C., Karger, A.
(2006). Composition of Pseudorabies Virus Particles Lacking Tegument Protein US3, UL47, or UL49 or Envelope Glycoprotein E. J. Virol.
80: 1332-1339
[Abstract]
[Full Text]
-
Pomeranz, L. E., Reynolds, A. E., Hengartner, C. J.
(2005). Molecular Biology of Pseudorabies Virus: Impact on Neurovirology and Veterinary Medicine. Microbiol. Mol. Biol. Rev.
69: 462-500
[Abstract]
[Full Text]